– Johnson & Johnson beat estimates by 11 cents a share, with quarterly earnings of $2.67 per share. Revenue came in slightly below forecasts.
J&J also suspended sales guidance for its Covid-19 vaccine due to a global supply surplus, and announced a 6.6% dividend hike. Shares initially fell more than 3% in the premarket but subsequently erased those losses.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Stock Futures Rise Ahead of Busy Earnings DayStock futures moved higher on Monday evening after stocks slipped during regular trading hours.
Read more »
Didi Global tumbles 17% after earnings, plans for shareholder meeting to discuss U.S. de-listingShares of Didi Global undefined dropped 17% in premarket trading on Monday, after the China ride-share group over the weekend announced a 12% drop in...
Read more »